510(k) K193589

TrueTear Intranasal Tear Neurostimulator by Allergan — Product Code QBR

K193589 is an FDA 510(k) premarket notification submitted by Allergan for the device "TrueTear Intranasal Tear Neurostimulator". The FDA issued a decision of Substantially Equivalent on Aug 31, 2020. The device falls under product code QBR (Intranasal Electrostimulation Device For Dry Eye Symptoms), a Class II device regulated under 21 CFR 886.5310. Allergan has 38 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Aug 31, 2020
Date Received
Dec 23, 2019
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Intranasal Electrostimulation Device For Dry Eye Symptoms
Device Class
Class II
Regulation Number
886.5310
Review Panel
OP
Submission Type
510(k)

This device type is intended to temporarily increase tear production using neurostimulation to improve dry eye symptoms. For prescription use only.

Need the full FDA record for Allergan? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K193589. Report a data issue: hello@regdatalab.com.